How ‘China speed’ is reshaping cross-border BD — a Perspective

The flow of deals involving China assets has at last grabbed everyone’s attention in the Western biotech community, much like most now know the phrase “China speed” to describe everything from the changing skyline in China cities to how quickly products move through the clinic.

What’s new with China biotech is that deal flow is now moving at China speed — in some weeks there’s literally a China “deal of the day.” Adding to the momentum, China’s biotechs are demonstrating how quickly they can pivot to hot indications like obesity, while also pushing into first-in-class innovation...